Back Pain Doctor
Hallux Rigidus (Stiff Big Toe)
Written by Dr Joshua Hatch, Musculoskeletal GP, RACGP Fellow, Diploma in Musculoskeletal Medicine (FSEM UK).
Hallux rigidus is osteoarthritis of the first metatarsophalangeal joint at the base of the big toe. Because this joint must bend with every step, even modest stiffness can make walking, running and pushing off uncomfortable.
Assessment focuses on how much movement remains at the joint, whether pain is coming from the bone spur on top of the joint or from within the joint itself, and whether foot alignment is contributing. A weight-bearing X-ray helps determine the stage. Other causes of forefoot pain, including gout, sesamoid problems and bunion-related pain, need to be considered when the pattern is unclear.
First-line care is usually footwear modification and offloading (a roomy toe box, a stiff or rocker-bottom sole, or a rigid forefoot insert) alongside activity adjustment and simple analgesia. Podiatry input is often useful at this stage. Where symptoms persist despite appropriate non-surgical care, or where joint changes are advanced, referral to an orthopaedic foot and ankle surgeon is appropriate to discuss surgical options.
Pain at the big toe joint that started suddenly with the toe forced upwards in sport is more likely a sprain of the joint, covered in the guide to turf toe.
Common symptoms
- Pain on the top of the big toe joint when walking
- Stiffness and reduced ability to bend the big toe
- A bump or thickening on top of the foot near the big toe
- Difficulty pushing off, or rolling onto the outside of the foot
Commonly seen in
Evidence for twelve treatment options in hallux rigidus (stiff big toe)
This is not a fixed ladder or a package of treatments. Every option is assessed independently against this diagnosis, including treatments with limited direct research that may still be reasonable for a clearly defined tissue target. The evidence level, likely benefit, risks, cost and alternatives are weighed at consultation.
Foundation: diagnosis, education and rehabilitation
The part of care with the broadest relevance. For many people it is enough on its own; other options are judged against it, not automatically added after it.
Diagnosis, education and progressive rehabilitation Working out what is driving the pain, explaining what your imaging does and does not mean, and building a graded loading plan you can actually follow. Core care
What it involves
Assessment to identify the likely pain source, an explanation of what the diagnosis means, adjustment of the loads that aggravate it, and a progressive strength and conditioning plan, with weight management where that is clinically relevant.
What the evidence shows
Exercise is the core treatment, and it performs as well as the tablets. A network meta-analysis of 152 randomised trials and 17,431 patients found exercise gave the same pain relief and functional improvement as oral anti-inflammatories and paracetamol, with a far better safety profile (Weng, Br J Sports Med 2023). EULAR (Moseng, Ann Rheum Dis 2024) and the American College of Rheumatology (Kolasinski, Arthritis Rheumatol 2020) both make exercise, education and weight management the core of non-pharmacological care. An individual-participant meta-analysis of 31 trials and 4,241 patients is clear about the size of it: the average effect is small and of questionable clinical importance, and those with more pain and worse function at the start benefit most (Holden, Lancet Rheumatol 2023).
Pairing reviewed 2026-09-02.
Where it fits
Worth being straight about: the average effect is modest, and it is larger for people who are struggling more to begin with. What it does have over the alternatives is that it is safe to keep doing, and it works on the things a joint injection cannot: strength, capacity and weight.
Muscle and symptom-modifying options
Useful only when the examination identifies the tissue they target or when short-term pain control creates a useful rehabilitation window.
Wet needling and trigger point injection (trigger point injection) A fine needle into a tender band of muscle, with a small volume of dilute glucose solution injected through it. Only if relevant
What it involves
The needle is placed into the tender muscle band and a small volume of 5% glucose with a very dilute local anaesthetic (0.02-0.08%) is injected. Often done in the same visit as your assessment, and usable where the tender area sits deeper. Dry needling (the same technique with nothing injected) is not offered here.
What the evidence shows
No study has tested any needling technique in hallux rigidus. A search pairing dry needling, trigger point needling and trigger point injection with arthritis of the shoulder, elbow, wrist, thumb base and big toe, including the terms hallux rigidus, hallux and first metatarsophalangeal joint, returned 19 records and none at the big toe; a second pass restricted to clinical trials returned none at the big toe either.
Pairing reviewed 2026-10-01.
Where it fits
Only where a separate tender muscle band in the foot or calf is reproducing part of the pain. It does not treat the stiff, arthritic joint.
Ultrasound-guided injections Guidance means the needle can be seen reaching the target. What goes into the needle depends on the diagnosis. Guided no better than blind
What it involves
The injection is performed under ultrasound so the needle can be watched into the target structure. What is injected is decided by the diagnosis, and corticosteroid is used sparingly, for the reasons set out below.
What the evidence shows
At the big toe joint, guidance was tested and did not change the result. In a single-blind randomised trial of 50 people, landmark-guided and ultrasound-guided corticosteroid injection improved pain and function equally at six weeks, with both groups improving significantly from baseline and no complications in either (Emami Razavi, Foot Ankle Int 2021). The injectate that has been tested against a dummy injection did not work: a Cochrane review of six trials in 547 people found, at moderate certainty, that a single hyaluronic acid injection gave no clinically important benefit over placebo, drawing on a randomised trial of 151 people (Munteanu, Cochrane Database Syst Rev 2024; Munteanu, Ann Rheum Dis 2011). No placebo-controlled trial of corticosteroid at this joint appears in that review.
Pairing reviewed 2026-09-10.
Where it fits
An option for settling a flare enough to get footwear and loading changes underway, rather than something to repeat. A rocker sole or stiff-soled shoe does more for this joint over time.
V-ACTOR vibration therapy (vibration therapy) Low-frequency vibration applied over tender muscle. Not a shockwave, despite sharing the machine. Plausible: no studies
What it involves
A vibration handpiece is moved over the tender muscle and fascia for a few minutes. It runs from the same STORZ MASTERPULS icon console as radial shockwave but is a separate handpiece delivering a different, gentler form of energy. No needles, no anaesthetic, no downtime.
What the evidence shows
No published clinical trial of this device in this condition. It is a vibration handpiece delivered from the same console as radial shockwave, and the rationale is myofascial rather than tendon- or bone-directed.
Pairing reviewed 2026-08-30.
Where it fits
A comfort measure used within a session where muscular tightness is limiting movement. Never the reason for the appointment, and not a substitute for the treatments that do have evidence.
Energy-based treatment options
Radial pressure wave, focused shockwave and EMTT have different targets and different evidence. They are assessed separately rather than treated as one category.
Radial or focused shockwave? Read the overviewRadial shockwave (radial pressure wave) Broad treatment across tender muscle and fascia, close to the surface. Technique report only
What it involves
A handpiece is moved over the tender tissue while ballistic pressure pulses are delivered, using a transmitter head chosen for the tissue, including heads shaped for fascia and for the muscle either side of the spine. The pulse is strongest at the skin and weakens with depth, so this is mainly a myofascial treatment, though it can reach deeper in some areas. No anaesthetic, no downtime, usually a course of sessions about a week apart.
What the evidence shows
There is no trial of shockwave of either device in hallux rigidus, and a search restricted to randomised trials returns nothing at this joint. What exists is a single technique report from a sports medicine group, who apply radial pressure waves over the big toe joint and the tendons and sesamoid bones around it, about 3,000 pulses at 2 to 3 bar, alongside foot strengthening and joint mobilisation. They report better toe extension and less pain with activity as clinical experience, with no control group and no outcome figures, and note that radial pulses over bone are painful and that the focused form may be better tolerated (Reilly, Video J Sports Med 2022).
Pairing reviewed 2026-10-04.
Where it fits
Considered for the tight, tender calf and foot muscle and the soft tissue around a stiff big toe joint, alongside the footwear change, a stiff-soled or rocker shoe and the mobility work that make the real difference. Over the joint itself it is uncomfortable, and the focused form is usually the better choice there.
Focused shockwave (ESWT) A true shock wave converging at depth: for tendon, joint, ligament and bone. Described, not yet trialled
What it involves
A focused system generates an acoustic shock wave that converges at a focal point set at a defined depth, concentrating the energy where the target is. This is the form used for tendon, joint, ligament and bone. Typically four to six sessions about a week apart, no anaesthetic and no formal downtime.
What the evidence shows
Shockwave for a stiff, painful big toe joint has been described but not trialled. A sports medicine group reports using it alongside foot strengthening and joint mobilisation, applying it over the joint and the soft tissue around it, and notes that the focused form is better tolerated over bone than radial pressure waves. They report better toe extension and less pain with activity as clinical experience, without a control group or outcome figures (Reilly, Video J Sports Med 2022). No randomised trial exists at this joint; the trial evidence for shockwave in osteoarthritis is at the knee and hip (Tang, Int J Surg 2024; Şah, J Pers Med 2022).
Pairing reviewed 2026-10-04.
Where it fits
A reasonable option to try for a painful big toe joint that has not settled with footwear changes and mobility work, with the gap in the evidence explained. Treatment over the joint is uncomfortable while it is being done. It will not restore movement that is blocked by bone spurs.
EMTT (magnetotransduction therapy) High-energy magnetic pulses applied over the area. Usually painless, no contact. Plausible: no studies
What it involves
You sit with the applicator positioned over the area for a short session. It is usually painless and needs no gel or skin contact. It is usually given as a course, commonly alongside shockwave.
What the evidence shows
There are no published randomised trials of EMTT in this condition, or in any musculoskeletal condition, that could be identified. The supporting work is laboratory work: EMTT increased tenocyte proliferation, migration and collagen expression in cultured human tendon cells (Mancini, Int J Mol Sci 2025). The nearest human evidence for a related electromagnetic therapy is negative. A randomised trial of pulsed electromagnetic field therapy added to eccentric exercise for Achilles tendinopathy found no improvement in outcome scores or tendon neovascularity over eccentric exercise alone (Ko, Orthop J Sports Med 2024).
Pairing reviewed 2026-08-30.
Where it fits
Offered only as an adjunct alongside treatment that does have evidence, never as the plan itself, and only after that gap is explained. Much of the EMTT literature is manufacturer-affiliated, which is part of why it is described this way.
Biologic and joint injection options
Each injection is assessed independently for the named diagnosis. Cost, uncertainty, likely benefit, risks and alternatives are part of the decision.
Platelet-rich plasma (PRP) Your own blood, concentrated and injected under ultrasound guidance. Only studied alongside surgery
What it involves
Blood is taken from your arm, spun to concentrate the platelets, and injected into the target under ultrasound guidance in the same appointment.
What the evidence shows
No study of a PRP injection for an arthritic big toe joint was found. Searches on 8 October 2026 across hallux rigidus, hallux limitus, the first metatarsophalangeal joint and the great toe returned 8 and then 15 records, and the only one indexed as a randomised trial was in horses. In people, PRP at this joint has been reported as part of an operation: 45 people had the joint surface resected and covered with a PRP-soaked implant, with better scores and movement at one and two years but no comparison group, so the PRP cannot be separated from the surgery (Siclari, Foot Ankle Surg 2017). The nearest controlled evidence is from the ankle, where PRP was no better than saline in a trial of 100 people (Paget, JAMA 2021), and across foot and ankle trials PRP was followed by more pain at the injection site than comparison injections (odds ratio 2.23), with one extra complication for about every 13 people treated (Fucaloro, Arthroscopy 2025).
Pairing reviewed 2026-10-08.
Where it fits
Can be discussed on the knee-based rationale where a stiff-soled or rocker shoe and load changes have not been enough, with it stated that nobody has studied the injection at this joint and that the nearest trial, at the ankle, found no benefit over saline. Not a first-line option.
Prolotherapy (dextrose) A course of dextrose injections into and around the structure and its attachments. Plausible: no studies
What it involves
Hypertonic dextrose is injected at the tender ligament and tendon attachments, and into the joint where relevant, usually as a series of treatments a few weeks apart.
What the evidence shows
No clinical study of prolotherapy in big-toe arthritis. A search on 12 October 2026 for dextrose or prolotherapy in arthritis of the elbow, wrist or big toe returned four records. The only foot report was a professional dancer who had big-toe arthritis on imaging but was given prolotherapy, among several treatments, for instability of the second toe joint (Ojofeitimi, J Orthop Sports Phys Ther 2016). The trials of dextrose injection into an arthritic joint are in the knee and the fingers (Chen, Clin Rehabil 2022; Reeves, J Altern Complement Med 2000).
Pairing reviewed 2026-10-12.
Where it fits
Prolotherapy is offered here and can be discussed for big-toe arthritis pain that persists despite stiff-soled or rocker-bottom footwear and activity changes, with the absence of studies at this joint stated. It does not remove a bone spur that is blocking the joint.
Viscosupplementation (hyaluronic acid) A gel-like injection into an arthritic joint. Widely used, and genuinely contested. No better than saline in a large trial
What it involves
One or a short series of hyaluronic acid injections into the joint under ultrasound guidance.
What the evidence shows
Searched PubMed for the same hyaluronic acid terms with hallux or first metatarsophalangeal (16 records; 2 trials and 2 reviews). This is evidence of absence, not absence of evidence. In the one placebo-controlled trial, 151 people had a single image-guided hylan injection or saline into the big-toe joint; foot pain at three months was no different and there were few differences on any other measure (Munteanu, Ann Rheum Dis 2011). A Cochrane review rated this as moderate-certainty evidence of little or no difference in pain or function (Munteanu, Cochrane Database Syst Rev 2024). The more positive studies have no placebo group: hyaluronic acid eased walking pain more than cortisone at four and eight weeks in 37 people (Pons, Foot Ankle Int 2007), and pain fell from 6.5 to 2.8 out of 10 at three months in an uncontrolled series of 65, 15 of whom had a temporary flare (Galois, Clin Med Insights Arthritis Musculoskelet Disord 2022).
Pairing reviewed 2026-10-26.
Where it fits
Not a first-line option for big-toe arthritis: the one trial that compared it with saline found no difference. Footwear changes, a stiff or rocker-sole insert and a loading program come first, with other guided injections considered if these are not enough.
Nerve-targeted options
Relevant when examination identifies a superficial neuropathic pattern or a compressed peripheral nerve, not simply because pain is present.
Lyftogt perineural therapy (perineural injection therapy) A series of small dilute dextrose injections just under the skin, over tender superficial nerves. Nerve targets only
What it involves
Small injections of low-concentration dextrose, usually 5%, placed just beneath the skin along tender superficial nerves. Given as a series of short sessions.
What the evidence shows
Searched at the great toe, and every human result is about a nerve rather than the joint. The largest series is 59 ultrasound-guided perineural injections in 46 people at the foot and ankle, where the commonest single target was the hallux branch of the medial plantar nerve (17 of 59); 43 of 45 reported immediate relief and 23 of 38 with follow-up had a period of lasting relief, with one complication - but the injectate was local anaesthetic and the indication was nerve pathology, most often a thickened, scarred nerve (Walter, Skeletal Radiol 2017). No study injects dilute dextrose under the skin for an arthritic big toe joint. Two of the five records the great-toe search returned were veterinary studies of sesamoid nerve blocks in horses, so the small count overstates the human literature.
Pairing reviewed 2026-09-28.
Where it fits
Considered only where a tender, hypersensitive skin nerve territory is found over the forefoot rather than pain arising from the joint itself. Stiffness and pain at the end of range in the joint is not what this treats.
Ultrasound-guided nerve hydrodissection Fluid placed around a nerve to free it from the surrounding tissue. Only if relevant
What it involves
Under ultrasound, fluid is placed in the plane around the nerve to separate it from the tissue that is tethering or compressing it.
What the evidence shows
Hydrodissection evidence is concentrated in ultrasound-confirmed peripheral nerve entrapment, especially carpal tunnel syndrome; no direct evidence was identified for this diagnosis itself. Condition reviewed: hallux rigidus.
Evidence source: Buntragulpoontawee et al., hydrodissection injectate review (2021)
Pairing reviewed 2026-08-30.
Where it fits
For hallux rigidus, hydrodissection may be considered only if ultrasound and examination identify a separate compressed or tethered peripheral nerve. It is not treatment of the primary diagnosis.
This is general information only and suitability is assessed individually. Treatments with limited or condition-dependent evidence may still be discussed, but only with clear explanation of the uncertainty, the expected benefit, risks, cost and alternatives. Red flags, progressive neurological symptoms or suspected serious pathology require a different pathway.
Every treatment above is described in full on the non-surgical treatments page, including what each one is used for and what the evidence supports. Ratings apply to the named diagnosis; an adjacent muscle, tendon, joint or nerve problem is assessed as a separate target. The method behind the ratings, and the treatments not offered, are set out on the evidence page.
Corticosteroid injection is reviewed separately for each diagnosis.
Cortisone reliably reduces pain in the short term, and that can be genuinely useful when pain is stopping you sleeping or moving enough to rehabilitate. Beyond that window the picture changes. A systematic review of 41 randomised trials and 2,672 participants found that corticosteroid injection reduced pain in the short term but that the effect reversed at intermediate and long term; in pooled analysis for lateral epicondylalgia the short-term effect was large (SMD 1.44, 95% CI 1.17 to 1.71) while no intervention was favoured at 26 weeks (-0.40, -0.67 to -0.14) and at 52 weeks (-0.31, -0.61 to -0.01) (Coombes, Lancet 2010). In a randomised trial in lateral epicondylalgia, 83 per cent of the corticosteroid group had completely recovered or much improved at one year against 96 per cent given a placebo injection, and recurrence ran at 54 per cent against 12 per cent; adding physiotherapy made no significant difference at one year (Coombes, JAMA 2013). In joints, repeated corticosteroid injections have been associated with cartilage loss. It does not repair anything.
So treatment plans are not built around it. Where an injection is the right call, the specific diagnosis and target are reviewed, what is being injected and why is discussed, the number is kept low, and it is paired with the loading work that changes the longer-term course.
When it might still be considered
- Pain severe enough to block rehabilitation
- A clear inflammatory or bursal target on imaging
- A specific short-term goal: a trip, a procedure, a return to work
- Diagnostic use, where the response shows where the pain is coming from
When a cortisone injection is worth doing, and when it is not
Other foot, ankle & lower leg conditions
Pain in the same area can come from more than one source, and the label matters less than what the examination and history point to. These are the other guides for this region.
Frequently asked questions
How is hallux rigidus diagnosed?
Can non-surgical treatment help?
When is surgery considered?
Ready for a clearer plan for your back or musculoskeletal pain?
Book an assessment with Dr Joshua Hatch.
Your assessment focuses on understanding the likely source of your pain and the most appropriate non-surgical options for your diagnosis, with the aim of reducing pain and improving function.
You must have your own regular GP before booking. This service works alongside your GP for focused care. Booking requirements.
Book an appointment